Search results for "choline"

showing 10 items of 1138 documents

Nerves projecting from the intrinsic cardiac ganglia of the pulmonary veins modulate sinoatrial node pacemaker function

2013

Rationale: Autonomic nerves from sinoatrial node (SAN) ganglia are known to regulate SAN function. However, it is unclear whether remote pulmonary vein ganglia (PVG) also modulate SAN pacemaker rhythm. Objective: To investigate whether in the mouse heart PVG modulate SAN function. Methods and Results: In hearts from 45 C57BL and 7 Connexin40+/GFP mice, we used tyrosine-hydroxylase (TH) and choline-acetyltransferase (ChAT) immunofluorescence labeling to characterize adrenergic and cholinergic elements, repectively, within the PVG and SAN. PVG project postganglionic nerves to the SAN. TH and ChAT stained nerves, enter the SAN as an extensive, dense mesh-like neural network. Neurons in PVG are…

Malemedicine.medical_specialtysinoatrial nodepulmonary veinsPhysiologyAdrenergicMice TransgenicStimulationIn Vitro TechniquesMiceFetal HeartBiological ClocksHeart Conduction SystemHeart RatePhysiology (medical)Internal medicineAtrial FibrillationHeart ratemouse heartmedicineAnimalsHumansSinus rhythmIntrinsic cardiac gangliaSinoatrial NodeSinoatrial nodebusiness.industryOriginal ArticlesMiddle AgedElectric StimulationElectrophysiological PhenomenaMice Inbred C57BLoptical mappingAtropinemedicine.anatomical_structureEndocrinologyPulmonary Veinscardiac arrhythmiasCatheter AblationCardiologyCholinergicFemaleGangliaElectrical conduction system of the heartCardiology and Cardiovascular Medicinebusinessmedicine.drugCardiovascular Research
researchProduct

Nicotine enhances antisaccade performance in schizophrenia patients and healthy controls

2013

Abstract Nicotine has been proposed to be a cognitive enhancer, particularly in schizophrenia patients. So far, the published studies of nicotine effects on antisaccade performance in schizophrenia patients only tested participants who were deprived smokers. Thus, we aimed to test both smoking and non-smoking patients as well as healthy controls in order to extend previous findings. Moreover, we employed a paradigm using standard and delayed trials. We hypothesized that, if nicotine is a genuine cognitive enhancer, its administration would improve antisaccade performance both in smoking and non-smoking participants. A total of 22 patients with schizophrenia (12 smokers and 10 non-smokers) a…

Malemedicine.medical_treatmentStatistics as TopicNicotine2738 Psychiatry and Mental Health0302 clinical medicine2736 Pharmacology (medical)Pharmacology (medical)Nicotinic AgonistsCotinineCross-Over StudiesSmokingCognitionMiddle Aged16. Peace & justice3. Good healthPsychiatry and Mental healthNicotinic acetylcholine receptor3004 PharmacologySchizophreniaFemaleSmoking statusPsychologymedicine.drugClinical psychologyAdultNicotinemedicine.medical_specialtyAdolescentNicotine patch610 Medicine & healthAdministration CutaneousYoung Adult03 medical and health sciencesDouble-Blind MethodInternal medicineReaction TimeSaccadesmedicineHumansEffects of sleep deprivation on cognitive performanceBeneficial effectsPharmacologyAnalysis of Variancemedicine.disease030227 psychiatryElectrooculography10054 Clinic for Psychiatry Psychotherapy and PsychosomaticsSchizophrenia030217 neurology & neurosurgery
researchProduct

The contribution of acetylcholine and dopamine to subprocesses of visual working memory--what patients with amnestic mild cognitive impairment and Pa…

2014

Attentional selection, i.e. filtering out of irrelevant sensory input and information storage are two crucial components of working memory (WM). It has been proposed that the two processes are mediated by different neurotransmitters, namely acetylcholine for attentional selection and dopamine for memory storage. However, this hypothesis has been challenged by others, who for example linked a lack in dopamine levels in the brain to filtering deficits. Here we tested the above mentioned hypothesis in two patient cohorts which either served as a proxy for a cholinergic or a dopaminergic deficit. The first group comprised 18 patients with amnestic mild cognitive impairment (aMCI), the second 22…

Malephysiopathology [Cognitive Dysfunction]Parkinson's diseaseCognitive NeuroscienceDopamineModels NeurologicalExperimental and Cognitive Psychologyphysiopathology [Brain]Neuropsychological TestsCohort StudiesBehavioral Neurosciencechemistry.chemical_compoundDopaminemedicineHumansAttentionCognitive Dysfunctionddc:610metabolism [Dopamine]NeurotransmitterAgedWorking memoryDopaminergicBrainCognitionParkinson Diseasephysiopathology [Amnesia]Middle Agedphysiology [Visual Perception]medicine.diseaseAcetylcholineMemory Short-Termchemistryphysiology [Memory Short-Term]physiology [Attention]Visual PerceptionCholinergicFemalephysiopathology [Parkinson Disease]AmnesiaPsychologyNeurosciencemetabolism [Acetylcholine]Acetylcholinemedicine.drugNeuropsychologia
researchProduct

Drug‐refractory myasthenia gravis: Clinical characteristics, treatments, and outcome

2022

[Objective] To describe the clinical characteristics and outcomes in patients with refractory myasthenia gravis (MG) and to determine the effectiveness and side effects of the drugs used for their treatment.

Maleprogressive multifocal leukoencepdiarrheacholinergic receptorplasma exchangemiddle agedadultimmunologic factornauseaanemiahypertrichosisageddrug withdrawaldiabetes mellitusdisease severityTRIALsafetycorticosteroidhypertensionImmunologyMiastenia gravismethotrexateArticlebulbar paralysispancytopeniaMuscular DiseasescompulsionMyasthenia Gravischolinesterase inhibitorcross-sectional studyHumansImmunologic FactorshumanRITUXIMABarthralgiaNeurologíaMalalties muscularsAgedRetrospective Studiesmyasthenia gravisleukopeniaabdominal painDrug testingmajor clinical studyCross-Sectional StudiesDrug side effectscyclophosphamideobservational studyNeurology (clinical)immunoglobulinFEATURESefficacyclinical outcomeelectrophysiological procedurescomputer assisted tomographyDOUBLE-BLINDTratamiento médicorituximabOutcome Assessment Health CareImmunologiamuscle specific tyrosine kinaseRegistriestacrolimusazathioprineMedicamentoGeneral Neurosciencenephrotoxicitygeneral condition deteriorationhyperplasiatrialMiddle Agedliver toxicitydrug toxicityunclassified drugfemaleEfectes secundaris dels medicamentsSAFETYFemaledouble-blindheadacheblindnessAdultAssaigs clínics de medicamentsmalefeaturesfollow uppneumoniacyclosporinemycophenolate mofetilprotein tyrosine kinaseimmunosuppressive agentallergyalopeciaEFFICACYclinical featureosteopeniaSpainprednisonehyperglycemiaautoantibodyFollow-Up Studies
researchProduct

Impact of tiotropium + olodaterol on physical functioning in COPD: results of an open-label observational study

2016

Rüdiger Sauer,1 Michaela Hänsel,2 Roland Buhl,3 Roman A Rubin,4 Marcel Frey,5 Thomas Glaab2,3 1Lung Centre Ulm, Ulm, Germany; 2Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, Germany; 3Pulmonary Department, Mainz University Hospital, Mainz, Germany; 4Pulmonary Specialist Practice, Wiesbaden, Germany; 5Biometrics, Alcedis GmbH, Gießen, Germany Background: Maintaining and improving physical functioning is key to mitigating the cycle of deconditioning associated with chronic obstructive pulmonary disease (COPD). We evaluated the impact of free combination of the long-acting anticholinergic tiotropium plus the long-acting β2-agonist ol…

Malereal-worldTime FactorsnoninterventionalHealth StatusSeverity of Illness IndexCholinergic AntagonistsPulmonary Disease Chronic Obstructivechemistry.chemical_compound0302 clinical medicinetiotropiumDeconditioningPhysical functioningSurveys and QuestionnairesProspective Studies030212 general & internal medicineLungOriginal ResearchCOPDOlodaterolGeneral MedicineTiotropium bromideMiddle AgedBronchodilator AgentsDrug CombinationsTreatment OutcomeFemalemedicine.drugmedicine.medical_specialtymedicine.drug_classInternational Journal of Chronic Obstructive Pulmonary Diseasechronic obstructive pulmonary disease03 medical and health sciencesAdministration InhalationSeverity of illnessmedicineAnticholinergicphysical functioningHumansTiotropium BromideIntensive care medicineAdrenergic beta-2 Receptor AgonistsAgedolodaterolbusiness.industryNebulizers and VaporizersRecovery of Functionmedicine.diseaseBenzoxazines030228 respiratory systemchemistryPhysical therapyObservational studybusinessInternational Journal of Chronic Obstructive Pulmonary Disease
researchProduct

Long-Term Response to Cholinesterase Inhibitor Treatment Is Related to Functional MRI Response in Alzheimer's Disease.

2015

<b><i>Background:</i></b> Treatment of Alzheimer's disease (AD) with cholinesterase inhibitors (ChEI) enhances cholinergic activity and alleviates clinical symptoms. However, there is variation in the clinical response as well as system level changes revealed by functional MRI (fMRI) studies. <b><i>Methods:</i></b> We investigated 18 newly diagnosed mild AD patients with fMRI using a face recognition task after a single oral dose of rivastigmine, a single dose of placebo and 1-month treatment with rivastigmine. The clinical follow-up took place at 6 and 12 months. <b><i>Results:</i></b> MMSE score difference between bas…

Malevsual processingCognitive NeuroscienceRivastigmineDiseasePharmacologyNeuropsychological TestsAlzheimerin tautimmoryta3112behavioral disciplines and activitiesBrain mappingAlzheimer DiseasemedicineHumansCholinesteraseAgedRivastigmineAged 80 and overmuistisairaudetBrain Mappingmedicine.diagnostic_testbiologyBrainMagnetic resonance imagingMiddle Agedmedicine.diseaseMagnetic Resonance Imagingta3124Psychiatry and Mental healthLong term responsecolinesterase inhibitorbiology.proteinCholinergicFemaleCholinesterase InhibitorsGeriatrics and GerontologyAlzheimer's diseasePsychologyAlzheimer’s diseaseNeurosciencepsychological phenomena and processesmgnetic resonance imagingmedicine.drugDementia and geriatric cognitive disorders
researchProduct

Influence of different parameters on drug release from hydrogel systems to a biomembrane model. Evaluation by differential scanning calorimetry techn…

2000

A comparative study on the drug release capacity of four water swellable polymeric systems was carried out by differential scanning calorimetry (DSC). The polymeric systems chosen were alpha,beta-polyaspartahydrazide (PAHy) crosslinked by glutaraldehyde (GLU) (PAHy-GLU) or by ethyleneglycoldiglycidylether (EGDGE), (PAHy-EGDGE), polyvinylalcohol (PVA) crosslinked by glutaraldehyde (PVA-GLU) and alpha,beta-poly(N-hydroxyethyl)-DL-aspartamide (PHEA) by gamma irradiation (PHEA-gamma matrices). The degree of crosslinking for PAHy-GLU, PAHy-EGDGE and PVA-GLU samples was about 0.4 and 0.8. These hydrogels were characterized as free of drugs and were loaded with diflunisal (DFN) (approximately 2.5%…

Materials science12-DipalmitoylphosphatidylcholinePolymersBiophysicsDiflunisalBioengineeringBiocompatible Materialsmacromolecular substancesBiomaterialschemistry.chemical_compoundDifferential scanning calorimetryDrug Delivery SystemsPolymer chemistryMaterials TestingmedicinePolyhydroxyethyl MethacrylateLiposomeCalorimetry Differential ScanningEpoxy ResinsVesicletechnology industry and agricultureHydrogelsMembranes ArtificialDiflunisalControlled releaseNylonsCross-Linking ReagentsHydrazineschemistryChemical engineeringMechanics of MaterialsGlutaralDipalmitoylphosphatidylcholineDelayed-Action PreparationsPolyvinyl AlcoholSelf-healing hydrogelsLiposomesCeramics and CompositesGlutaraldehydemedicine.drug
researchProduct

Modification of human platelet adhesion on biomaterial surfaces by protein preadsorption under static and flow conditions.

2004

Biomaterial-induced thrombosis remains one of the main complications of vascular implant devices. Preadsorbed proteins on the biomaterial/blood interface will modify the adhesion and activation of platelets (PTLs) during the initial contact-phase. Our results clearly show that PTL-adherence on biomaterials is influenced not only by protein preadsorption, but also by flow conditions. The covalent coating of TCPS and glass by phosphorylcholine (PC) induces a significant decrease of PTL adhesion but leads to a slight, but nevertheless significant activation of PTL, which was detected by the induction of P-selectin expression using FACS analysis. Methodologically, the visualization of PTL adhes…

Materials scienceBiomedical EngineeringBiophysicschemistry.chemical_elementBioengineeringBiocompatible MaterialsCalciumIn Vitro TechniquesBiomaterialsBlood cellPlatelet AdhesivenessIn vivoMaterials TestingmedicineHumansPlateletPhosphorylcholineBiomaterialThrombosisAdhesionBlood ProteinsFlow CytometryPlatelet ActivationBiomechanical PhenomenaBlood Vessel ProsthesisP-Selectinmedicine.anatomical_structurechemistryembryonic structuresImmunologyHemorheologyBiophysicsAdsorptionProtein adsorptionJournal of materials science. Materials in medicine
researchProduct

Plasmonic Nanosensors for the Label-Free Imaging of Dynamic Protein Patterns.

2020

We introduce a new approach to monitor the dynamics and spatial patterns of biological molecular assemblies. Our molecular imaging method relies on plasmonic gold nanoparticles as point-like detectors and requires no labeling of the molecules. We show spatial resolution of up to 5 μm and 30 ms temporal resolution, which is comparable to wide-field fluorescence microscopy, while requiring only readily available gold nanoparticles and a dark-field optical microscope. We demonstrate the method on MinDE proteins attaching to and detaching from lipid membranes of different composition for 24 h. We foresee our new imaging method as an indispensable tool in advanced molecular biology and biophysic…

Materials scienceCardiolipinsLipid BilayersMetal NanoparticlesNanotechnologyCell Cycle Proteins02 engineering and technology010402 general chemistry01 natural sciencesNanosensorFluorescence microscopeEscherichia coliGeneral Materials SciencePhysical and Theoretical ChemistryImage resolutionPlasmonAdenosine TriphosphatasesMicroscopyNanotubesEscherichia coli ProteinsPhosphatidylglycerols021001 nanoscience & nanotechnology0104 chemical sciencesMembraneColloidal goldTemporal resolutionPhosphatidylcholinesGoldMolecular imaging0210 nano-technologyThe journal of physical chemistry letters
researchProduct

An ultrasonic-assisted process for copper recovery in a des solvent: Leaching and re-deposition

2017

Abstract The continuous growth of the electronic equipment market has led to an increased amount of scraping that it becomes necessary to recover. A hydrometallurgical method for copper and precious metal recovery from e-waste must consist of a number of steps: leaching, ion separation and subsequent electrochemical re-deposition of the target metal. Although this task is achievable in aqueous solutions, it requires strong acid or cyanide solutions. The aim of the study is to develop a new environmentally benign process by using a Deep Eutectic Solvent (DES), a form of cheap and safe ionic liquid, as an electrolyte for both leaching and electrodeposition. The experiments were conducted in a…

Materials scienceGeneral Chemical EngineeringSonicationInorganic chemistryEnergy Engineering and Power Technologychemistry.chemical_element02 engineering and technologyElectrolyteSolvent extraction and electrowinning010402 general chemistry01 natural sciencesIndustrial and Manufacturing Engineeringchemistry.chemical_compound[CHIM]Chemical SciencesComputingMilieux_MISCELLANEOUSAqueous solutionProcess Chemistry and TechnologyGeneral Chemistry021001 nanoscience & nanotechnologyCopper0104 chemical sciencesDeep eutectic solventchemistryLeaching (metallurgy)0210 nano-technologyCholine chloride
researchProduct